MedPath

Parsabiv

Brand Name: Parsabiv

Generic Name: Etelcalcetide (as hydrochloride)

Expiring Soon
Registration Number

DR-XY17134

Dosage Form

Solution for Intravenous Injection

Issuance Date

December 21, 2020

Expiry Date

December 21, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL
Packaging3 mL-capacity USP/Ph. Eur. Type I clear and colorless borosilicate glass vial with a 13 mm fluoropolymer laminated elastomeric stopper and an aluminum seal with flip-off dust cover (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Etelcalcetide (as hydrochloride)Active
Monograph: Etelcalcetide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform